SBIR/STTR Research Award
SYNTHESIS OF ANTITUMOR AGENTS RELATED TO FREDERICAMYCIN A
Award amount
$50,000Program and phase
SBIR · Phase IAward year
1987Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- Merix Corp
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
THE OBJECTIVE OF THIS PHASE I PROPOSAL IS TO DISCOVER NOVEL ANTITUMOR AGENTS THAT MAY OFFER THERAPEUTIC ADVANTAGES OVER THOSE CURRENTLY AVAILABLE. THIS RESEARCH PROGRAM WILL BE BASED ON THE CHEMICAL SYNTHESIS OF CERTAIN ANALOGS OF THE ANTITUMOR ANTIBIOTIC FREDERICAMYCIN A. THESE ANALOGS MAY POSSESS GREATER POTENCY, BETTER DRUG DELIVERY PROPERTIES, AND FEWER SIDE EFFECTS THAN THE PARENT NATURAL PRODUCT. IN ADDITION, THE ANALOGS SYNTHESIZED IN THIS STUDY MAY PROVIDE CLUES TO THE BIOCHEMICAL MECHANISM OF ACTION OF FREDERICAMYCIN A.
Technology keywords
Not reported